9,485
Total Claims
$2.6M
Drug Cost
1,338
Beneficiaries
$1,911
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+25%
Cost per patient vs peers
$1,911 vs $1,524 avg
+54%
Brand preference vs peers
21.1% vs 13.7% avg
Opioid Prescribing
0.1%
Opioid Rate
14
Opioid Claims
$71
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
79% generic
Brand: 2,000 claims · $2.3M
Generic: 7,485 claims · $215K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,357 | $1.7M |
| Rivaroxaban | 327 | $443K |
| Sacubitril/Valsartan | 56 | $75K |
| Dronedarone Hcl | 27 | $59K |
| Dofetilide | 157 | $34K |
| Potassium Chloride | 220 | $28K |
| Empagliflozin | 13 | $21K |
| Evolocumab | 16 | $18K |
| Flecainide Acetate | 239 | $17K |
| Diltiazem Hcl | 471 | $17K |
| Metoprolol Succinate | 616 | $14K |
| Dabigatran Etexilate Mesylate | 24 | $14K |
| Ivabradine Hcl | 11 | $13K |
| Amiodarone Hcl | 491 | $10K |
| Midodrine Hcl | 39 | $8,569 |
Prescribing Profile
66
Unique Drugs
$2.2M
Patient Profile
76
Avg Age
46%
Female
1.57
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data